Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1954551000168113 | Tazocin EF 2 g/250 mg (piperacillin 2 g + tazobactam 250 mg) powder for injection, 1 x 2.25 g vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1954561000168110 | Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | Is a | piperacillin 2 g + tazobactam 250 mg injection, 2.25 g vial | true | Inferred relationship | Some | ||
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | has TPUU | Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | true | Inferred relationship | Some | 1 | |
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | has TP | Tazocin EF 2 g/250 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | Is a | True | Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR